HSBC HOLDINGS PLC - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 149 filers reported holding IMMUNOVANT INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q4 2022$862,421
+21.1%
49,592
-61.6%
0.00%0.0%
Q3 2022$712,000
+46.5%
129,289
+5.6%
0.00%0.0%
Q2 2022$486,000
-21.0%
122,420
+11.4%
0.00%0.0%
Q1 2022$615,000
-32.3%
109,939
+4.6%
0.00%0.0%
Q4 2021$909,000
+78.2%
105,073
+83.4%
0.00%0.0%
Q3 2021$510,000
+39.3%
57,288
+625.3%
0.00%
Q4 2020$366,000
-23.9%
7,899
-39.8%
0.00%
-100.0%
Q3 2020$481,000
-21.8%
13,120
-48.1%
0.00%0.0%
Q2 2020$615,000
+37.6%
25,273
-12.1%
0.00%0.0%
Q1 2020$447,00028,7420.00%
Other shareholders
IMMUNOVANT INC shareholders Q4 2020
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders